Rice Hall James & Associates’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Buy
262,842
+12,823
+5% +$26.4K 0.02% 217
2026
Q1
$338K Buy
250,019
+9,190
+4% +$18.5K 0.02% 230
2025
Q4
$626K Buy
240,829
+13,805
+6% +$37.7K 0.03% 212
2025
Q3
$681K Buy
227,024
+105,369
+87% +$376K 0.04% 213
2025
Q2
$489K Buy
+121,655
New +$449K 0.03% 222

Other funds holding BTMD

Rice Hall James & Associates's BTMD Position: Q2 2026 in Review

Rice Hall James & Associates increased its Biote Corp (BTMD) stake by 5.1% in Q2 2026, buying an estimated $26.4K and bringing the position to 262,842 shares worth $497K. The position accounts for 0.02% of the portfolio, ranked #217.

Rice Hall James & Associates first reported a position in BTMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $681K in Q3 2025. 71 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

  • Rice Hall James & Associates held 262,842 shares of Biote Corp worth $497K as of Q2 2026.
  • Rice Hall James & Associates bought 12,823 Biote Corp shares in Q2 2026, an estimated $26.4K.
  • Biote Corp made up 0.02% of Rice Hall James & Associates's portfolio in Q2 2026, its #217 holding.
  • Rice Hall James & Associates first reported a position in Biote Corp in Q2 2025 and has held it in 5 quarters since.
  • Rice Hall James & Associates's Biote Corp position peaked at $681K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.